Xartemis
Pricing Report NDC 23635-115-01

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Xartemis Xr (NDC 23635-115-01) is $2.25632 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 20, 2016.

As a provided by Specgx Llc, this medication is distributed in a 100 TABLET, COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$2.25632
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Apr 20, 2016
Billable Units
100 EA
Estimated Package Price
$225.63
Data Status
As of May 10, 2017
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
23635-115-01
Description
100 TABLET, COATED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jun 2014, the NADAC wholesale price for (NDC ) has moved within a range of $2.21994 to $2.27802 per EA. Over this 1 year and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$2.2199 - $2.2780
Market Volatility
2.62% Variance
Latest Trend
1.28%
Date Unit Price Unit Source Method Rate
Apr 20, 2016 $2.25632 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 20, 2016 $2.25632 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Apr 20, 2016 $2.25632 EAC/I - Chain or Independent PharmacyCode 4B - Brand
May 20, 2015 $2.22785 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2015 $2.22785 EAC/I - Chain or Independent PharmacyCode 2B - Brand
May 20, 2015 $2.22785 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Mar 18, 2015 $2.27802 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2015 $2.27802 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jul 23, 2014 $2.21994 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 23, 2014 $2.21994 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jun 18, 2014 $2.22506 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026